Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantum Genesis AI (QTZM) Accounts Payables (2018 - 2026)

Quantumzyme's Accounts Payables history spans 4 years, with the latest figure at $169733.0 for Q1 2026.

  • For Q1 2026, Accounts Payables changed N/A year-over-year to $169733.0; the TTM value through Jan 2026 reached $169733.0, changed N/A, while the annual FY2025 figure was $175218.0, 59.61% up from the prior year.
  • Accounts Payables reached $169733.0 in Q1 2026 per QTZM's latest filing, down from $205573.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $205573.0 in Q4 2025 to a low of $109780.0 in Q3 2024.
  • Average Accounts Payables over 3 years is $161195.2, with a median of $169733.0 recorded in 2026.
  • The largest YoY upside for Accounts Payables was 59.61% in 2025 against a maximum downside of 59.61% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $109780.0 in 2024, then soared by 87.26% to $205573.0 in 2025, then dropped by 17.43% to $169733.0 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Accounts Payables are $169733.0 (Q1 2026), $205573.0 (Q4 2025), and $175218.0 (Q3 2025).